当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析 - 资产负债表

华仁药业

(300110)

  

流通市值:41.43亿  总市值:41.50亿
流通股本:11.80亿   总股本:11.82亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金112,162,748.61232,043,523.45200,230,911.97349,092,940
应收票据及应收账款664,626,179.01656,365,193.38649,721,442.25668,123,857.68
其中:应收票据1,430,046.721,638,566.022,094,517.971,506,733.07
应收账款663,196,132.29654,726,627.36647,626,924.28666,617,124.61
应收款项融资112,521,985.87149,740,915.4297,892,265.7977,641,138.49
预付款项40,284,829.1138,521,219.9585,581,368.25104,591,592.81
其他应收款合计1,371,029,375.151,364,138,561.771,405,480,505.671,417,419,877.23
存货319,194,970.4334,628,729.51342,318,260.46297,680,112.38
其他流动资产15,044,824.615,988,116.1919,724,526.3915,596,227.01
流动资产平衡项目0000
流动资产合计2,634,864,912.752,791,426,259.672,800,949,280.782,930,145,745.6
非流动资产:
其他权益工具投资15,984,62415,984,62415,984,62415,984,624
投资性房地产9,316,133.649,388,194.189,460,254.729,532,315.26
固定资产1,053,523,312.031,072,846,506.921,053,776,689.181,062,058,021.56
在建工程42,407,995.9441,947,342.8522,531,600.9535,921,927.69
使用权资产910,834.091,055,175.331,264,999.681,525,573.43
无形资产313,809,564.29318,531,668.97318,193,165.67323,396,526.64
开发支出13,462,643.0613,042,521.7722,462,273.8417,590,285.27
商誉820,041,620.38820,041,620.38826,287,819.54826,287,819.54
长期待摊费用13,519,60716,054,890.8315,816,023.6612,286,415.1
递延所得税资产42,982,176.4142,033,994.1262,089,253.8359,619,396.79
其他非流动资产40,561,701.6723,344,258.8923,025,361.4322,367,485.05
非流动资产平衡项目0000
非流动资产合计2,366,520,212.512,374,270,798.242,370,892,066.52,386,570,390.33
资产平衡项目0000
资产总计5,001,385,125.265,165,697,057.915,171,841,347.285,316,716,135.93
流动负债:
短期借款453,339,869.77624,828,010.88666,439,101.52876,825,943.24
应付票据及应付账款132,171,493.16142,322,851.18126,432,270.91142,305,400.42
应付账款132,171,493.16142,322,851.18126,432,270.91142,305,400.42
合同负债40,156,392.8655,547,782.1123,270,709.3732,329,950.88
应付职工薪酬16,935,053.4822,985,569.5518,386,366.8720,293,136.54
应交税费22,024,043.8832,387,284.0243,951,876.1327,443,502.88
其他应付款合计234,370,358.88212,535,760.14254,191,584.63277,288,851.53
应付股利---24,826,472.62
一年内到期的非流动负债626,693,317.9419,998,315.8607,453,181.88571,484,601.88
其他流动负债5,220,331.075,654,444.363,025,192.224,202,893.61
流动负债平衡项目0000
流动负债合计1,530,910,8611,516,260,018.041,743,150,283.531,952,174,280.98
非流动负债:
长期借款605,857,796.33836,420,000665,881,768.68657,278,242.47
租赁负债145,934.25163,080.2428,930.41,020,075.18
长期应付职工薪酬00855,641.63855,641.63
递延收益175,412.49175,412.49219,265.62219,265.62
递延所得税负债45,961,520.1946,723,130.5248,086,962.9748,169,406.07
非流动负债平衡项目0000
非流动负债合计652,140,663.26883,481,623.21715,472,569.3707,542,630.97
负债平衡项目0000
负债合计2,183,051,524.262,399,741,641.252,458,622,852.832,659,716,911.95
所有者权益(或股东权益):
实收资本(或股本)1,182,212,9821,182,212,9821,182,212,9821,182,212,982
资本公积528,044,115.47528,044,115.47528,044,115.47528,044,115.47
盈余公积84,617,614.584,617,614.577,102,308.8177,102,308.81
未分配利润950,039,935.03899,217,018.15855,789,703.48800,981,537.83
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,744,914,6472,694,091,730.122,643,149,109.762,588,340,944.11
少数股东权益73,418,95471,863,686.5470,069,384.6968,658,279.87
股东权益平衡项目0000
股东权益合计2,818,333,6012,765,955,416.662,713,218,494.452,656,999,223.98
负债和股东权益合计5,001,385,125.265,165,697,057.915,171,841,347.285,316,716,135.93
公告日期2024-04-252024-04-252023-10-252023-08-26
审计意见(境内)标准无保留意见
TOP↑